nivolumab
bms
['sclc', 'nivolumab', 'nivo', 'check,mate,816', 'nsclc']
#asco22 an update from checkmate 816 (dr. ) - this regimen (3 cycles of neoadjuvant nivolumab + chemotherapy) has been approved for resectable stage ii/iii nsclc. improved pcr and efs and approved march 2022. 
Director of Thoracic Oncology & Developmental Therapeutics @LombardiCancer, Associate Professor @Georgetown University #LCSM #HereWeGo #ITYSL He/Him